Phase 2 Bipolar Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with bipolar disorder, where the diagnosis has been confirmed using a structured clinical interview called a SCAN interview
- People who are between 18 and 70 years of age
- People who are able to read and understand participant information written in either English or Danish
- People who are able to give informed consent for themselves (meaning no one else is legally required to make decisions on their behalf)
Who may not be able to join:
- People who have previously had an allergic reaction or intolerance to melatonin
- People who have reduced kidney or liver function, as measured by specific blood and urine tests falling outside accepted ranges (confirm with trial site)
- People who are pregnant, breastfeeding, or planning to become pregnant in the near future
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lars Kessing, University hospital Bispebjerg and Frederiksberg Hospital
Phone: +45 38647081
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mood stabilization
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.